Fatemeh Kheradmand

Dr. Fatemeh Kheradmand


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Reproductive Toxicology
Verified
Journal Article
Closed access
NPNazila Pourhassanali
Nazila Pourhassanali
SRShiva Roshan-Milani
Shiva Roshan-Milani
FKFatemeh Kheradmand
Fatemeh Kheradmand
MMMorteza Motazakker
Morteza Motazakker
MBmorteza bagheri
morteza bagheri
ESEhsan Saboory
Ehsan Saboory

19 March 2016 in International Journal of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
SASomayeh Atari-Hajipirloo
Somayeh Atari-Hajipirloo
NVNeda Valizadeh
Neda Valizadeh
MKMohammad-Hassan Khadem-Ansari
Mohammad-Hassan Khadem-Ansari
YRYousef Rasmi
Yousef Rasmi
FKFatemeh Kheradmand
Fatemeh Kheradmand
Altered Concentrations of Copper, Zinc, and Iron are Associated With Increased Levels of Glycated Hemoglobin in Patients With Type 2 Diabetes Mellitus and Their First-Degree Relatives - International Journal of Endocrinology and Metabolism - - Kowsar

1 January 2017 in Research in Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
FKFatemeh Kheradmand
Fatemeh Kheradmand
MMMahshid Mohammadian
Mahshid Mohammadian
SZShima Zeynali
Shima Zeynali
AAAnahita Fathi Azarbayjani
Anahita Fathi Azarbayjani
MAMohammad Hassan Khadem Ansari
Mohammad Hassan Khadem Ansari
The use of heat shock protein 90 inhibitors like 17-allylamino-17-demethoxy-geldanamycin (17-AAG) has been recently introduced as an attractive anticancer therapy. It has been shown that 17-AAG may potentiate the inhibitory effects of some classical anticolorectal cancer (CRC) agents. In this study, two panels of colorectal carcinoma cell lines were used to evaluate the effects of 17-AAG in combination with capecitabine and oxaliplatin as double and triple combination therapies on the proliferation of CRC cell lines. HT-29 and all HCT-116 cell lines were seeded in culture media in the presence of different doses of the mentioned drugs in single, double, and triple combinations. Water-soluble tetrazolium-1 (WST-1) assay was used to investigate cell proliferation 24 h after treatments. Then, dose-response curves were plotted using WST-1outputs, and IC50 values were determined. For double and triple combinations respectively 0.5 × IC50 and 0.25 × IC50 were used. Data was analyzed with the software CompuSyn. Drug interactions were analyzed using Chou-Talalay method to calculate the combination index (CI).The data revealed that 17-AAG shows a potent synergistic interaction (CI < 1) with oxaliplatin and capecitabine in double combinations (0.5 × IC50) in both cell lines. In the case of triple combinations, the findings showed an antagonistic interaction (CI > 1) in HT-29 and a synergistic effect (CI < 1) in HCT-116 (0.25 × IC50) cell lines. It was concluded that double combinations of 17-AAG with oxaliplatin or capecitabine might be effective against HCT-116 and HT-29 cell lines. However, in triple combinations, positive results were seen only against HCT-116. Further investigation is suggested to confirm the effectiveness of these combinations in clinical trials.

1 September 2014 in International Journal of Computer Applications Technology and Research
Verified
Journal Article
Closed access
PDF file
AKAzam Kaboutari
Azam Kaboutari
JBJamshid Bagherzadeh
Jamshid Bagherzadeh
FKFatemeh Kheradmand
Fatemeh Kheradmand
International Journal of Computer Applications Technology and Research (IJCATR) archive

1 February 2019 in Gene
Verified
Journal Article
Closed access
SZShima Zeynali-Moghaddam
Shima Zeynali-Moghaddam
MMMahshid Mohammadian
Mahshid Mohammadian
FKFatemeh Kheradmand
Fatemeh Kheradmand
AAAnahita Fathi Azarbayjani
Anahita Fathi Azarbayjani
YRYousef Rasmi
Yousef Rasmi
HMHassan Malekinejad
Hassan Malekinejad

21 February 2015 in Hepatitis Monthly
Verified
Journal Article
Open access
PDF file
MAMohammad Hassan Khadem Ansari
Mohammad Hassan Khadem Ansari
MOMir-Davood Omrani
Mir-Davood Omrani
FKFatemeh Kheradmand
Fatemeh Kheradmand
Background: The molecular mechanism of hepatitis C-virus (HCV) genome-specific pathogenesis remains unclear. Oxidative stress is an important pathophysiological mechanism in chronic HCV infection, but its relation to HCV genotypes has not been thoroughly examined. Objectives: In the present case-control study, the effect of diverse HCV genotypes on oxidative status changes was investigated. Patients and Methods: From 310 patients examined by enzyme immunoassay and PCR, 160 patients with positive results for HCV with previously determined genotypes were chosen. For the control group, 160 first time blood donors referred to the Regional Blood Transfusion organization of the West Azerbaijan province, northwestern Iran were selected. Oxidative stress markers such as total antioxidant status (TAS), serum levels of reduced (GSH) and oxidized (GSSG) glutathione, Gamma-glutamyl transferase (GGT) and malondialdehyde (MDA) were evaluated in patients infected with diverse HCV genotypes and those in the control group. Results: In the patient and control groups, the mean ± SE of TAS, GSH, GSSG, GGT and MDA were 1.04 ± 0.35 vs. 2.68 ± 0.77, 1.25 ± 0.37 vs. 3.12 ± 0.58, 0.20 ± 0.05 vs. 0.08 ± 0.04, 26.82 ± 5.62 vs 8.28 ± 2.03 and 2.56 ± 0.60 vs. 0.93 ± 0.34. All markers had statistical difference between the two groups (P <0.05). Obvious differences were found in oxidant/antioxidant balance among diverse HCV genotypes with an ascending trend in antioxidant levels among patients infected with genotypes 1a/b, 4, 2a/c, 2b, 3a and healthy controls and a vice versa trend in measures of oxidative markers except for malondialdehyde with a variable pattern. Conclusions: More serious disease in HCV genetic subtype 1a/1b might be associated with more severe oxidative stress. Milder damage in subtypes 4, 2a/c, 2b and 3a could be related to lower oxidative response, respectively. A combination of antiviral and antioxidative therapies may enhance the overall response rate of patients with HCV infection, especially with more destructive genotypes. Keywords: Antioxidant; Glutathione; Gamma-Glutamyl Transferase; Malondialdehyde; Hepatitis C